MIRA INFORM REPORT
|
Report
Date : |
27.01.2007 |
IDENTIFICATION
DETAILS
|
Name : |
ROSSARI BIOTECH (INDIA) PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
401, Omega, Main Street, Hiranandani Gardens, Powai,
Mumbai-400076, Maharashtra |
|
|
|
|
Country
: |
India |
|
|
|
|
Financials
(as on) : |
31.03.2006 |
|
|
|
|
Date
of Incorporation : |
31.01.1997 |
|
|
|
|
Com.
Reg. No.: |
11-105584 |
|
|
|
|
CIN
No.: [Company Identification No.] |
U24100MH1997PTC105584 |
|
|
|
|
TAN
No.: (Tax Deduction & Collection Account No.) |
MUMR15313E |
|
|
|
|
PAN
No.: (Permanent Account No.) |
AABCR2094R |
|
|
|
|
Legal
Form : |
Private Limited Liability Company |
|
|
|
|
Line
of Business : |
Manufacturers
and Exporters of Chemicals |
RATING & COMMENTS
|
MIRA’s
Rating : |
Ba |
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered
normal. Capable to meet normal commitments. |
Satisfactory |
|
Maximum
Credit Limit : |
USD
100000 |
|
|
|
|
Status
: |
Satisfactory
|
|
|
|
|
Payment
Behaviour : |
Usually
Correct |
|
|
|
|
Litigation
: |
Clear |
|
|
|
|
Comments
: |
Subject is a well-established company having satisfactory
track records. Directors are reported as experienced respectable and
resourceful businessmen. Their trade relations are fair. General financial
position is good. Payments are usually correct and as per commitments. The company can be considered normal for business dealings
at usual trade term and conditions. |
LOCATIONS
|
Registered
Office : |
401, Omega, Main Street, Hiranandani Gardens, Powai,
Mumbai-400076, Maharashtra India. |
|
Tel.
No.: |
91-22-25709200/01 |
|
Fax
No.: |
91-22-25709210 |
|
E-Mail
: |
|
|
Website
: |
|
|
Area : |
Owned |
|
|
|
|
Corporate
Office : |
3, Milan Street, St. Plus Colony, St. Plus Street, Mulund
(West), Mumbai - 400 080, Maharashtra. |
|
|
|
|
Factory : |
Nhavasheva Port, Mumbai, Maharashtra |
DIRECTORS
|
Name : |
Mr. Sunil
Srinivasan Chari |
|
Designation
: |
Director |
|
Address
: |
B-902, Vallncia, Hiranandani Gardens, Powai, Mumbai-400076 |
|
Date
of Birth/Age : |
05/12/1965 |
|
Date
of Appointment : |
31/01/1997 |
|
|
|
|
Name : |
Mr.
Edward Alphanso Menezes |
|
Designation
: |
Director |
|
Address
: |
601/602, Gem House, Hiranandani Gardens, Powai,
Mumbai-400076 |
|
Date
of Birth/Age : |
31/10/1960 |
|
Date
of Appointment : |
31/01/1997 |
MAJOR SHAREHOLDERS
|
Names of Shareholders |
|
No. of Shares |
|
Mr.
Edward A. Menezes |
|
27550 |
|
Mr. Sunil
S. Chari |
|
28050 |
|
Mr. Irene
A. Menezes |
|
2298 |
|
Mrs. Usha
S. Chari |
|
1000 |
|
Mr. Irene
A. Menezes |
|
1 |
|
Neutron
Impex Private Limited |
|
10400 |
|
Menzes
Mikhait Through F and NG Edward Menses |
|
500 |
|
Chari
Yash Through F and NG Sunil Chari |
|
300 |
|
Sunil
Chari (HUF) |
|
650 |
BUSINESS DETAILS
|
Line
of Business : |
Manufacturers
and Exporters of Chemicals |
|
|
|
|
Products
: |
Chemical |
|
|
|
|
Exports
to : |
Bangladesh, Sri Lanka, UAE,
Malaysia, Australia, Kenya, Jordan, New Zealand, Venezuela, China, Nepal |
PRODUCTION STATUS
|
Particulars |
Unit |
|
Installed Capacity |
Actual Production |
|
Chemicals |
Kgs |
|
1100000 |
793990.77 |
GENERAL INFORMATION
|
No. of
Employees : |
30 |
|
|
|
|
Bankers
: |
Citi Bank Andhra Bank Mulund (West) Branch, M.G. Road
Mumbai - 400 080, Maharashtra HDFC Bank HDFC Bank House,
Senapati Bapat Marg, Lower Parel [West], Mumbai – 400013, Maharashtra, India Andhara Bank, Mulund Branch , Mulund (W) , Mumbai-400080 |
|
|
|
|
Banking Relations : |
Satisfactory
|
|
|
|
|
Auditors
: |
Lahoti
& Lahoti Chartered
Accountants Bipin G. Mundade, 202, Surbhi, G. V. Scheme Road No. 2,
Mulund (East), Mumbai - 400 081,
Maharashtra |
|
Tel.
No.: |
91-22-25682819 |
|
Telefax
No..: |
91-22-55991680 |
|
E-Mail
: |
|
|
|
|
|
Associates/Subsidiaries
: |
Ø Biotech India Private Limited Ø Neutron Impex Private Limited CIN No.: U24110MH2004PTC121848 Ø Rossari Biotech Ø Rossari Specialities |
CAPITAL STRUCTURE
Authorised
Capital :
|
No. of
Shares |
Type |
Value |
Amount |
|
100000 |
Equity Shares |
Rs.10 each |
Rs. 1.000 millions |
|
150000 |
Preference Shares |
Rs.10 each |
Rs. 1.500 millions |
|
|
Total |
|
Rs. 2.500 Millions |
Issued,
Subscribed & Paid-up Capital :
|
No. of
Shares |
Type |
Value |
Amount |
|
71100 |
Equity Shares |
Rs.10 each |
Rs. 0.711 millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS
FUNDS |
|
|
|
|
|
1] Share
Capital |
0.711 |
0.711 |
0.711 |
|
|
2] Share
Application Money |
0.000 |
0.000 |
0.000 |
|
|
3]
Reserves & Surplus |
26.857 |
23.055 |
20.928 |
|
|
4]
(Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
NETWORTH
|
27.568 |
23.766 |
21.639 |
|
|
LOAN
FUNDS |
|
|
|
|
|
1]
Secured Loans |
0.338 |
0.583 |
0.538 |
|
|
2]
Unsecured Loans |
4.039 |
2.031 |
7.773 |
|
TOTAL
BORROWING
|
4.377 |
2.614 |
8.311 |
|
|
DEFERRED
TAX LIABILITIES |
0.000 |
0.000 |
0.023 |
|
|
|
|
|
|
|
TOTAL
|
31.945 |
26.380 |
29.973 |
|
|
|
|
|
|
|
APPLICATION OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block]
|
5.299 |
6.158 |
7.343 |
|
|
|
|
|
|
|
INVESTMENT
|
7.035 |
0.118 |
0.118 |
|
DEFERREX TAX ASSETS
|
0.090 |
0.014 |
0.000 |
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES
|
|
|
|
|
|
|
Inventories
|
0.913
|
0.331
|
0.000 |
|
|
Sundry Debtors
|
144.398
|
20.622
|
10.126 |
|
|
Cash & Bank Balances
|
0.428
|
1.054
|
1.707 |
|
|
Other Current Assets
|
0.000
|
0.000
|
0.000 |
|
|
Loans & Advances
|
17.561
|
16.670
|
15.484 |
Total Current Assets
|
163.300
|
38.677
|
27.317 |
|
Less : CURRENT LIABILITIES & PROVISIONS
|
|
|
|
|
|
|
Current Liabilities
|
143.460
|
18.155
|
3.584 |
|
|
Provisions
|
0.320
|
0.435
|
1.225 |
Total Current Liabilities
|
143.780
|
18.590
|
4.809 |
|
Net
Current Assets
|
19.520 |
20.087
|
22.508 |
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES
|
0.001 |
0.003 |
0.004 |
|
|
|
|
|
|
|
TOTAL
|
31.945 |
26.380 |
29.973 |
|
PROFIT & LOSS ACCOUNT
|
PARTICULARS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
Sales Turnover [including other income]
|
411.741 |
60.621 |
44.329 |
|
|
|
|
|
Profit/(Loss) Before Tax
|
3.929 |
2.242 |
0.080 |
Provision for Taxation
|
0.000 |
0.115 |
0.023 |
Profit/(Loss) After Tax
|
3.929 |
2.127 |
0.057 |
|
|
|
|
|
Export Value
|
N.A. |
N.A. |
0.561 |
|
|
|
|
|
Import Value
|
N.A. |
N.A. |
0.231 |
|
|
|
|
|
Total Expenditure
|
407.812 |
57.282 |
42.090 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
31.03.2004 |
PAT / Total Income
|
(%)
|
0.95 |
3.51
|
0.13 |
|
|
|
|
|
|
Net Profit Margin
(PBT/Sales) |
(%) |
0.95 |
3.70
|
0.18 |
|
|
|
|
|
|
Return on Total Assets
(PBT/Total
Assets} |
(%) |
2.33 |
5.00
|
0.23 |
|
|
|
|
|
|
Return on Investment (ROI)
(PBT/Networth) |
|
0.14 |
0.09
|
0.00 |
|
|
|
|
|
|
Debt Equity Ratio
(Total
Liability/Networth) |
|
5.37 |
0.89
|
0.61 |
|
|
|
|
|
|
Current Ratio
(Current
Asset/Current Liability) |
|
1.14 |
2.08
|
5.68 |
LOCAL AGENCY FURTHER INFORMATION
Fixed
Assets :
Ø
Building
Ø
Furniture
and Fittings
Ø
Motor
Car
Ø
Plant
and Machinery
Ø
Office
Equipments
Ø
Two
Wheeler
Ø
Computer
Systems
Ø
Telephones
Ø
Electrical
Installations
Subject is incorporated
to carry on the business of manufacturers, processors, producers, importers,
exporters, buyers, sellers, traders, suppliers, stockists, agents, merchants,
distributors and dealers in chemicals, chemicals compounds, organic and
inorganic dyes, textile and textile auxiliaries.
Its product
range includes:
Ø
Antifung
SP Conc
Ø
D Soft
New
Ø
Dymax
NDA
Ø
Newfade
PUN Pdr
Ø
Temper
VLF New Liquid
Ø
Temper
VLF New
Ø
Zycol SNE
SU
Ø
Zywet
P 100
The company endeavor to provide a company platform for
exchange of information view by industry expresses a medium to spread technical
and commercial knowledge through the bimonthly publication fussers was been
well received and appreciated. The company is the any one to publish fussers in
English Hindi and Tamil.
The prospects for the companies are bright during the year
the company has achieved rebut growth and were able to clock a 41% increase in
turn over as compared to previous year.
Details relating to investment in Capital of Partnership
Firm
|
Name of the Firm |
Name of Partners |
Profit sharing Ratio
|
|
M/S Rossati Biotech |
Rossari Biotech India Private Limited |
10 % |
|
|
Mr. Sunil Chari |
45 % |
|
|
Mr. Edward Menezes |
45 % |
|
|
|
|
|
M/S Rossari Specialities |
Rossari Biotech India Private Limited |
10 % |
|
|
Mr. Sunil Chari |
45 % |
|
|
Mr. Edward Menezes |
45 % |
|
Name of the company |
ROSSARI CHEMICALS INDIA
PRIVATE LIMITED |
|
Presented By |
Mr. Sunil Chari , Director |
|
1) Date and description of instrument creating the change |
Letter confirming creation of the equitable Mortgage by
deposit of title deeds on 16th March 2000 |
|
2) Amount secured by the charge/amount owing on the
securities of charge |
Rs. 3.000 millions |
|
3) Short particular of the property charged. If the
property acquired is subject to charge, date of the acquired of the property
should be given |
Equitable mortgage created by deposit of title deeds in
respect of immovable properties 401 Omega Building, Hirandani Garden sitiated
at Powai Mumbai 400076, Bearing CTS No 6/7/20/21/22 (all parts) 23/24 and 25
(parts) |
|
4) Gist of the terms and conditions and extent and
operation of the charge. |
Interest @ 16 % p.a. Security to secure Term Loan together with interest, cost,
expenses, Charges, commission etc. |
|
5) Name and Address and description of the person entitled
to the charge. |
Andhara Bank, Mulund Branch , Mulund (W) , Mumbai-400080 |
|
6) Date and brief
description of instrument modifying the charge |
NIL |
|
7) Particulars of modifications specifying the terms and
conditions or the extent of operations of the charge in which modification is
made and the details of the modification. |
NIL |
|
|
|
|
Name of the company |
ROSSARI CHEMICALS INDIA
PRIVATE LIMITED |
|
Presented By |
Mr. Edward Menezes , Director |
|
1) Date and description of instrument creating the change |
Composite Hypothecation Agreement dated 11/03/2003
executed by Rossari Biotech India Private Limited (Hereafter referred to as
“the company”) in favour of Citibank N.A. (therein and hereinafter referred to
as "the ledger ”) |
|
2) Amount secured by the charge/amount owing on the
securities of charge |
Total facilities for Rs. 25.000 millions of which Rs.
17.500 millions is funded and Rs. 7.500 millions is non funded facilities. |
|
3) Short particular of the property charged. If the
property acquired is subject to charge, date of the acquired of the property
should be given |
Hypothecation of all the present and future book debts,
outstanding monies, receivables, claims, bills contracts, securities,
investments, goodwill, rights of and assets as security for due repayment to
the Bank many time on demand the total balance outstanding in the various
accounts along with the interest at the rate hereinafter provided including
all costs. And also such other goods, properties and machinery that may be
brought into by the Borrowers and stored/planted and fitted in the premises
aforesaid after execution of this agreement and during its currency. |
|
4) Gist of the terms and conditions and extent and
operation of the charge. |
In consideration of the lender having agreed to lend
advance to the company said facilities under the said agreement and
declaration by the company, inter alias as follows. Covenant by the company to repay the facility at 2 above
and pay interest and all other monies in the manner set out in the said
agreement between the company and the lender and to comply with the terms and
conditions of the said agreement. The said assets hypothecated to the Lender as and by way
of First charge, as security for and be charged with the repayment of the
loan with all interest, liquidated, damages premier on prepayment or on redemption costs charges, and other
expenses payable by the company to the lender in respect thereof. Margin 36 % on
stocks and 52 % on book debts. The companies to keep the said assets in marketable and
good conditions and also insured as provided therein Power of entry, power to take charge and or passion of
size, recover, revive appoint and sell, contract, dispatch for realization on
otherwise dispose of or deal with all or any part of the said assets, etc as
provided therein. |
|
5) Name and Address and description of the person entitled
to the charge. |
CITI Bank N.A. Bandra Kurla Complex G-Block Bandra (E) Mumbai-400051 |
|
6) Date and brief
description of instrument modifying the charge |
Not Applicable |
|
7) Particulars of modifications specifying the terms and
conditions or the extent of operations of the charge in which modification is
made and the details of the modification. |
Not Applicable |
|
|
|
|
|
|
|
Name of the company |
ROSSARI CHEMICALS INDIA
PRIVATE LIMITED |
|
Presented By |
Mr. Edward Menezes , Director |
|
1) Date and description of instrument creating the change |
Loan Agreement and Memorandum of Entry dated
08/05/2003 executed by Rossari Biotech
India Private Limited (Hereafter referred to as “the company”) in favour ofc
Citibank N.A. (therein and hereinafter referred to as "the ledger ”) |
|
2) Amount secured by the charge/amount owing on the
securities of charge |
Total facilities for Rs. 25.000 millions of which Rs.
17.500 millions is funded and Rs. 7.500 millions is non funded facilities. |
|
3) Short particular of the property charged. If the
property acquired is subject to charge, date of the acquired of the property
should be given |
Mortgage of property being : Property situated at 401
Omega Building, Hirandani Garden , Powai Mumbai 400076 |
|
4) Gist of the terms and conditions and extent and
operation of the charge. |
In consideration of the lender having agreed to lend
advance to the company said facilities under the said agreement and
declaration by the company, inter alias as follows. Covenant by the company to repay the facility at 2 above
and pay interest and all other monies in the manner set out in the said
agreement between the company and the lender and to comply with the terms and
conditions of the said agreement. The said assets hypothecated to the Lender as and by way
of First charge, as security for and be charged with the repayment of the
loan with all interest, liquidated, damages premier on prepayment or on redemption costs charges, and other
expenses payable by the company to the lender in respect thereof. Margin 36 % on stocks and 52 % on book debts. The companies to keep the said assets in marketable and
good conditions and also insured as provided therein Power of entry, power to take charge and or passion of
size, recover, revive appoint and sell, contract, dispatch for realization on
otherwise dispose of or deal with all or any part of the said assets, etc as
provided therein. |
|
5) Name and Address and description of the person entitled
to the charge. |
CITI Bank N.A. Bandra Kurla Complex G-Block Bandra (E) Mumbai-400051 |
|
6) Date and brief
description of instrument modifying the charge |
Not Applicable |
|
7) Particulars of modifications specifying the terms and
conditions or the extent of operations of the charge in which modification is
made and the details of the modification. |
Not Applicable |
|
|
|
|
Name of the company |
ROSSARI CHEMICALS INDIA
PRIVATE LIMITED |
|
Presented By |
HDFC Bank Limited |
|
1) Date and description of instrument creating the change |
Letter of hypothecation of dated 26/04/2004 |
|
2) Amount secured by the charge/amount owing on the
securities of charge |
Rs. 60.000 millions |
|
3) Short particular of the property charged. If the
property acquired is subject to charge, date of the acquired of the property
should be given |
At the Stock in trade both and present and future
consisting of raw material, finished good goods in process of manufacturing
and other all the book debts, o/s
money receivable claims and bills which are now due or owner or which may at
any time hereafter shall continue to subsist till such time all the however
due have been repaid in full. Mortgage of properties situated at Flat No 401
Omega Building, Hirandani Garden , Powai Mumbai 400076 |
|
4) Gist of the terms and conditions and extent and
operation of the charge. |
The facility provided to the borrower in the nature. The bank in entitled to
charge interest at such rate as may be determined by the bank The charges and hypothecation shall continued to subsist
till such time all the borrower due have been repaid in full. The borrower
will at all times maintain a sufficient value of the receivable to provide
the margin of security regd, by the bank time to time |
|
5) Name and Address and description of the person entitled
to the charge. |
HDFC Bank Limited HDFC Bank House Senapati Bapat Marg, Lower Parel (W) Mumbai 400013 |
|
6) Date and brief
description of instrument modifying the charge |
NIL |
|
7) Particulars of modifications specifying the terms and
conditions or the extent of operations of the charge in which modification is
made and the details of the modification. |
NIL |
|
|
|
|
Name of the company |
ROSSARI CHEMICALS INDIA
PRIVATE LIMITED |
|
Presented By |
Andhara Bank, Mulund
Branch |
|
1) Date and description of instrument creating the change |
Agreement for cash credit dated 21.03.2001 Term Loan Agreement (Form A) dated 21.03.2001 Memorandum of Title deeds dated 21.03.2001 |
|
2) Amount secured by the charge/amount owing on the
securities of charge |
Open Cash Credit : Rs. 3.000 millions Term Loan II : Rs. 2.300 millions |
|
3) Short particular of the property charged. If the
property acquired is subject to charge, date of the acquired of the property
should be given |
Hypothecation of Stock of RM/FG/WIP lying in Factory and
office premises Equitable Mortgage of office premises situated at OMEGA
Building , Powai, Mumbai |
|
4) Gist of the terms and conditions and extent and
operation of the charge. |
Rate of interest : 15.75 % 25 % Margin on RM / FG 50 % Margin on WIP Personal Guarantee of Directors of the company |
|
5) Name and Address and description of the person entitled
to the charge. |
Andhara Bank, Mulund Branch , Mulund (W) , Mumbai-400080 |
|
6) Date and brief
description of instrument modifying the charge |
NIL |
|
7) Particulars of modifications specifying the terms and
conditions or the extent of operations of the charge in which modification is
made and the details of the modification. |
NIL |
|
Corporate
identity number of the company |
U24100MH1997PTC105584 |
|
Name of
the company |
ROSSARI
BIOTECH (INDIA) PRIVATE LIMITED |
|
Address
of the registered office or of the principal place of business in India of the company |
401,
Omega, Main Street, Hiranandani Gardens, Powai, Mumbai-400076, Maharashtra |
|
This form
is for |
Creation
of Charge |
|
Type of
charge |
Equitable
mortgage or mortgage of property by deposition the title deeds |
|
Particular
of charge holder |
HDFC Bank
HDFC
Bank House, Senapati Bapat Marg,
Lower Parel [West], Mumbai – 400013, Maharashtra, India |
|
Nature of
instrument creating charge |
Memorandum
Recording Transaction of creation of equitable mortgage by deposit of title
deeds |
|
Date of
instrument Creating the charge |
30.06.2006 |
|
Amount
secured by the charge |
Rs.
41.900 millions |
|
Brief of
the principal terms an conditions and extent and operation of the charge |
The bank
is entitled to charge interest at such other rate as may be determined by the
bank from time to time The
mortgage / charge shall continue to subsist till such time all the borrower
dues have been repaid in full together with interest, liquidated damages,
charges and costs and all other monies whatsoever dues |
|
Description
of the property charged indicating whether it is a charged on |
Immovable
properties |
|
Particulars
of the property charged |
Mortgage
by deposit of title deeds in favour of the bank as security on : Office
No. 401, 4th Floor, Omega, Powai, Mumbai New
Factory and Building at Naroli |
|
Corporate
identity number of the company |
U24100MH1997PTC105584 |
|
Name of
the company |
ROSSARI
BIOTECH (INDIA) PRIVATE LIMITED |
|
Address
of the registered office or of the principal place of business in India of the company |
401,
Omega, Main Street, Hiranandani Gardens, Powai, Mumbai-400076, Maharashtra |
|
This form
is for |
Creation
of Charge |
|
Type of
charge |
Equitable
mortgage or mortgage of property by deposition the title deeds |
|
Particular
of charge holder |
HDFC Bank
HDFC
Bank House, Senapati Bapat Marg,
Lower Parel [West], Mumbai – 400013, Maharashtra, India |
|
Nature of
instrument creating charge |
Memorandum
Recording Transaction of creation of equitable mortgage by deposit of title
deeds |
|
Date of
instrument Creating the charge |
24.04.2006 |
|
Amount
secured by the charge |
Rs. 8.000
millions |
|
Brief of
the principal terms an conditions and extent and operation of the charge |
The bank
is entitled to charge interest at such other rate as may be determined by the
bank from time to time The
mortgage / charge shall continue to subsist till such time all the borrower
dues have been repaid in full together with interest, liquidated damages, charges
and costs and all other monies whatsoever dues |
|
Description
of the property charged indicating whether it is a charged on |
Immovable
properties |
|
Particulars
of the property charged |
Mortgage
by deposit of title deeds in favour of the bank as security on : Office
No. 401, 4th Floor, Omega, Powai, Mumbai New
Factory and Building at Naroli |
AS PER WEBSITE
Rossari Biotech India Private Limited, an ISO 9001:2000 company was
incorporated in 1997.The company's role as an emerging giant in textile processing
industry is reflected in it's message. "POWER TO GROW WITH THE
NEEDS".
On
the leading edge of Chemicals & Bio-chemical technology, Rossari is driven
by young, dynamic technocrats that represent a new way of thinking and
practical approach to the textile industry's problem. The company's marketing
philosophy reinforces it's strong emphasis on product quality combining the
benefit offered by technical & sales service team. Our corporate office is
located at Mumbai - the finance center of India and our factory is also located
within close proximity to Mumbai, Nhavasheva port.
Rossari
is one stop-shop for textile processing. Product range dedicated to developing
radically new complete product gamut, consistent quality, reliability and
timely supplies. Using it's expertise and professional approach, Rossari will
continue to develop newer and better product with new processes best suited for
a variety of application satisfying stringent standard, properties and
ecological requirements
CUTTING
EDGE TECHNOLOGY :
Rossari's
name today is guarantee of best manufacturing practice, quality assurance and
total quality management.
All
made possible by manufacturing unit equipped with latest technology and an
efficient, trained workforce that sees the products to its final perfected
stage.
Parallel
with the commitment to product quality, is Rossari's commitment to service the
customer & meeting his needs. Flexibility & Reliability are two of the
most important objective in Rossari quality of service policy.
REACHING
GLOBAL MARKET :
Guarantee
of supply, consistent quality, affordability, strong technical back-up are just
some of the reason why Rossari product's finding growing acceptance in all
corner of the globe. At Rossari focus relentlessly on their customer. Because
of their resources, they compete effectively in ever changing world market. The
company's dedication to serve domestic & overseas customer with an ever
broadening range of quality products has resulted in an organization that is
successful by an standard.
TECHNICAL
SUPPORT :
Rossari
impressive technical resource are directed at streamlining it's manufacturing
capabilities & upholding quality standards. It's state-of-the art
laboratories are staffed by highly qualified people, whose collective expertise
fulfills the diverse requirement of a textile processing industry. Research
teams constantly explore the potential for newer molecules and manufacturing
new products, as well as optimizing processes.
Rossari can proudly claim
one of the best technical support and service team dedicated to look after
customer's requirements and problem.
Rossari
Biotech India Private Limited, an ISO 9001 : 2000 company and India’s largest
manufacturer of enzymes for textile processing, offers high concentrates and
standard formulations of Neutral Cellulose, Acid Cellulose, Engineered Acid
Cellulose (for low colour loss) Amylases, High Temperature Stable Amylases and
Catalyses, besides multizyme formulations for bioscouring, wool and silk
processing and print washing.
Rossari’s
new concept in textile processing which includes Colitz, Gamakleen, EBS
(Enzymatic bio-scouring) and new product range which includes Flameshield,
Fragma, Hydrogard, Snocool and Fabshield further reflects the company’s
dedication towards developing the quality products to meet customer’s
requirements.
Rossari’s
R & D center for Biotechnology Research located in New Mumbai India
constantly explore the potential for newer molecular and manufacturing new
products as well as optimizing the processes. State of the Art laboratory
staffed with highly qualified technocrats, fulfils the diverse requirement of a
textile processing industry.
To meet
the ever widening complex requirements of customer Rossari offers total
solutions through it’s wide range of textile auxiliaries and chemicals right
from pretreatment to finishing stage.
v
Rossari
Labtech is a new company, set up for dealing in Laboratory Machines,
Instruments and Standard Accessories to cater to the needs of Textile related
Industry.
v
Rossari
Labtech offers a wide range of machines and instruments for:
v
Yarn
testing and fabric testing
v
Dyeing
– Printing – Finishing and Testing
v
Accessories
and Standard Grey Scales.
These
products are designed and developed to meet latest technological requirements
and are user friendly. They play an important role in :
- Standardisation of recipes and
parameters
- Shade matching
- Developing new products,
recipes and process parameters
- Quality control checks
- Research and development
activities
- Academic institutes
Rossari
Labtech also offers ‘State of Art’ Laboratory Machines and Systems from the
leading companies from Taiwan, Korea and Europe.
ROSSARI BIOTECH INDIA PRIVATE LIMITED, is India’s largest manufacturer of
enzymes and one of the leading specialty chemical manufacturers for textile
processing. ROSSARI was incorporated in 1997 and within a short span of
5 years has made a name for itself in Domestic and now in International market
as well. Rossari’s success lies in its attitude towards solving customer
problems and providing them with technical services through its largest team of
technical executives in India." The countries to which they are exporting
their product are: Bangladesh, Sri
Lanka, UAE, Malaysia, Australia, Kenya, Jordan, New Zealand, Venezuela, China,
Nepal.
Rossari
Biotech India Private Limited, one of the leading manufactures of textile
specialty chemicals and enzymes is introducing “FABSHEILD“
Antimicrobial products and AEGIS Microbe Shield program. AEGIS Environment is
America's No.1 brand of Antimicrobials registered with EPA ( U.S Environmental
Protection Agency ) in 1976. Dow Corning Corporation is the world leading
manufacturers of silicones, which exclusively produce antimicrobials for AEGIS
in their ISO 9002 certified plant.
These type
of finishes prevents the growth of bacteria thus preventing diseases. It acts
as odor-eater too preventing the garments from unpleasant odors. The products
have been proved environmental friendly and health protecting.
The end us
application are sportswear, upholstery, medical purpose socks, undergarments,
building construction, etc where the growth of micro-organism are high needs to
be prevented also.
The
product are being used for over 20 years in textile and their product have been
used by world’s leading brands like Reebok, J.C Peeny, Adidas, WALMART, Marks
& Spencer, Kimberly Clark and major hospital like Arthur G. James Cancer
Hospital and Research Institute in USA etc.
In India,
this product has been used by Johnson & Johnson in sanitary napkins and
Aqua Guard Water Filter.
Rossari Biotech India
Private Limited is now an ISO 9001:2000 company.
Rossari is
proud to announce that it has been accredited with ISO 9001:2000
certification recently.
The
quality management system encompasses design, manufacturing and marketing of
enzymes and textile auxiliaries. It will enhance the customer satisfaction by
ensuring peak quality levels in products and services.
Add to
this, select band of stalwarts viz. Ms. Meher Castelino, Prof (Dr.) M. D. Teli
and Mr. V.C.Gupte, join the Editorial Board of Rossera (an in-house magazine),
which would augment to knowledge
outflow in the latest global happenings of textiles.
Meher
Castelino, a name synonymous with beauty and fashion. She is a pioneer in
fashion journalism in India. Author of MANSTYLE & FASHION
KALIEDOSCOPE, she is the full time fashion journalist & syndicated
columnist & has been promoting Indian Model and designers in
Dusseldorf since 1995.
Mr. V.C
Gupte, known for his “Computer Color Matching”
is presently working with
Advanced Graphic Systems (AGS), the sole distributor of Gretag Macbeth
& Gain Associates. He had carried out extensive work in application of CCM
techniques for textile process houses & has worked as an application
specialist on international circuit. His special contribution had been the
setting up of UDCT –GretagMacbeth/AGS Color science laboratory, which is the
only one of its kind in India.
Prof. (Dr.) M.D.Teli, dignified
personality in the field of textiles, is a full fledged professor for past 12
years and head of textile department of UICT. He is an Hon. Editor of Journal
of textile association for last 10 years & well versed with technical
development in various sectors of textile. Also he is known for organising a
number of national and international conference with Textile Association, India
& India – ITME Society. He has also completed successfully industrial
projects & consultancy assignments for various industries.
CMT REPORT
[Corruption, Money laundering & Terrorism]
The Public Notice information has been collected from
various sources including but not limited to: The Courts, India Prisons
Service, Interpol, etc.
1] INFORMATION ON DESIGNATED PARTY
No
records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that
subject is or was the subject of any formal or informal allegations,
prosecutions or other official proceeding for making any prohibited payments or
other improper payments to government officials for engaging in prohibited
transactions or with designated parties.
3] Asset Declaration :
No
records exist to suggest that the property or assets of the subject are derived
from criminal conduct or a prohibited transaction.
4] Record on Financial Crime :
Charges or
conviction registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any financial
crime or under any formal investigation by a competent government authority for
any violation of anti-corruption laws or international anti-money laundering
laws or standard.
8] Affiliation with Government :
No record exists to
suggest that any director or indirect owners, controlling shareholders,
director, officer or employee of the company is a government official or a
family member or close business associate of a Government official.
9] Compensation Package :
Our market survey
revealed that the amount of compensation sought by the subject is fair and
reasonable and comparable to compensation paid to others for similar services.
10] Press Report
:
No press reports / filings exists on the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments
on Corporate Governance to identify management and governance. These factors
often have been predictive and in some cases have created vulnerabilities to
credit deterioration.
Our Governance Assessment focuses principally on the
interactions between a company’s management, its Board of Directors,
Shareholders and other financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local
laws, regulations or policies that prohibit, restrict or otherwise affect the
terms and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 44.24 |
|
UK Pound |
1 |
Rs. 86.95 |
|
Euro |
1 |
Rs. 57.33 |
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound
financial base with the strongest capability for timely payment of interest
and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working
capital. No caution needed for credit transaction. It has above average
(strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base
are regarded healthy. General unfavourable factors will not cause fatal
effect. Satisfactory capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered
normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable
factors carry similar weight in credit consideration. Capability to overcome
financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent.
Repayment of interest and principal sums in default or expected to be in
default upon maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists.
Caution needed to be exercised |
Credit not recommended |